Publication|Articles|August 21, 2025
- Pharmaceutical Executive: August 2025
- Volume 45
- Issue 6
Pharmaceutical Executive: August 2025 Interactive Digital Edition
View the Pharmaceutical Executive August 2025 issue in an interactive format.
Advertisement
Click
Articles in this issue
12 months ago
The CAR-T Climb12 months ago
2025 Emerging Pharma Leaders12 months ago
An RNA-Guided Path12 months ago
Acceleration and Ambition12 months ago
Driving Disruption in Delivery12 months ago
Building Promise from Precision12 months ago
Determined Problem-Solver12 months ago
Direct-to-Consumer Prescription Care Comes of Age12 months ago
How to Get Product Iteration Right in HealthcareAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Significance of FDA’s First Warning Letter for Inappropriate Use of AI
2
Generating Commercial Evidence from Agentic Field and Brand Engagement to Accelerate Launch Performance
3
FDA Grants Accelerated Approval to Tudriqev in Combination with Nivoumab for Advanced Melanoma
4
Jazz Pharmaceuticals to Acquire Actio Biosciences for $1.32 Billion
5